Equity Analysis

Quarterly Results

    Sun Pharmaceuticals Industries Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524715
    INE044A01036
    100.2261618
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    SUNPHARMA
    88.43
    364315.02
    EPS(TTM)
    Face Value()
    Div & Yield %:
    17.17
    1
    0.76
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales4903.665019.544383.34
Other Operating Income170.0976.6782.73
Other Income 76.80106.54163.54
Total Income5150.555202.754629.61
Total Expenditure 3784.563709.893666.52
PBIDT1365.991492.86963.09
Interest 214.92193.63157.94
PBDT1151.071299.23805.15
Depreciation399.60392.71415.27
Tax30.1617.899.24
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax721.31888.63380.64
Extra-ordinary Items -67.010.00-145.67
Adjusted Profit After Extra-ordinary item788.32888.63526.31
EPS (Unit Curr.)3.003.701.60
EPS (Adj) (Unit Curr.)3.003.701.60
Calculated EPS (Unit Curr.)3.013.701.59
Calculated EPS (Adj) (Unit Curr.)3.013.701.59
Calculated EPS (Ann.) (Unit Curr.)12.0314.816.35
Calculated EPS (Adj) (Ann.) (Unit Curr.)12.0314.816.35
Book Value (Unit Curr.)0.000.000.00
Dividend (%)850.000.000.00
Equity239.93239.93239.93
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)27.8629.7421.97
PBDTM(%)23.4725.8818.37
PATM(%)14.7117.708.68
Dividend Per Share(Rs)8.500.000.00
Diluted EPS3.003.701.60